Includes a combination of an anti death antibody (PD-1) and another antibody

摘要

The current invention refers to the pharmacological composition, including a combination of an anticancer agent, the first antibody and the second antibody. In some cases, the first antibody is the planned - 1 (PD-1) antibody. In some cases, the composition is a fixed dose formula. In some cases, synthesis is managed as a standard dose. There is also a kit for treating patients that contains a dose of any ingredient that explains how to use the ingredient in any described method of treating the disease.